Obama
FDA sharpen focus on pharmaceutical companies under Trump
July 5, 2019Medical Communications FDA, Obama, Trump, USA, pharma, regulation
The overall number of warning letters being sent out by the FDA has dropped under President Donald Trump, according to …
New formulary ‘bank’ to aid research into combination therapies
January 11, 2017Medical Communications, Research and Development 21st Century Cures Act, Bristol-Myers Squibb, Eli Lilly, Joe Biden, Obama, bristol myers-squibb, combination therapy
As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …
Obama seals $6.3 billion 21st Century Cures Act
December 14, 2016Medical Communications, Research and Development Biden, Obama, US, congress
President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …
Almost half of US physicians will prescribe more biosimilars, according to survey
March 4, 2016Medical Communications Obama, US, biosimilar, patent, prescribing
New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …
Obama announces acceleration of Precision Medicines Initiative
February 26, 2016Medical Communications, Research and Development Obama, Precision Medicine, cancer moonshot, genomics
A year after Barack Obama announced the $200 million Precision Medicines Initiative (PMI), the US President yesterday outlined the next …
No ‘Plan B’ for Obamacare
June 18, 2015Medical Communications, Sales and Marketing ACT, Medicaid, Medicare, Obama, Obamacare, patient protection
US president Barack Obama has no ‘Plan B’ if a crucial Supreme Court vote in the next fortnight goes against …
US drug spend soars to all-time high in 2014
April 14, 2015Manufacturing and Production, Sales and Marketing Lipitor, Obama, UK Health and Social Care Information Centre, US, drug spend, prescribing
The number of prescriptions dispensed in the US rose by 13% in 2014 a new report has shown. The increase …
Pharma to profit from Obama reforms
March 18, 2015Sales and Marketing FDA, GlobalData, Obama, US, healthcare, insurance
President Obama’s healthcare reforms will drive massive growth in the US pharma market a new report is predicting. The size …
FDA commissioner steps down in March
February 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew von Eschenbach, FDA, Margaret Hamburg, Obama, Stephen Ostroff, US
The commissioner of the US Food and Drug Administration Dr Margaret Hamburg is to resign from her post at the …
George Freeman – a US blog
January 27, 2015Medical Communications, Sales and Marketing ABPI, Cameron, Kaiser Permanente, Obama, george freeman, google, life sciences
It is a privilege to have been appointed as the first ever minister for life sciences.I’m determined to ensure that …
Takeda: we’re working on Ebola too
November 24, 2014Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya
The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …
AbbVie ditches Shire as tax deal falters
October 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Obama, Shire, US government, tax, tax inversion
Tax rule changes coming from the US government have forced the collapse of a multi-billion dollar deal between Humira manufacturer …
AbbVie reconsiders Shire deal over tax laws
October 15, 2014Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax
AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …
US focus: still top of the pharma pile
June 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medicare, Obama, Sunshine Act, US, United States, america, report
Population: 313.9 million (2012) Government: Federal presidential republic Leader: President Barack Obama of the liberal Democratic Party Gross Domestic Product: …
US cancer docs warn of rising drug prices
May 7, 2014Research and Development, Sales and Marketing ASCO, Cancer, NICE, Obama, US, United States, republicans
American cancer doctors are warning that the rising price of oncology medicines is making it unaffordable for the country’s healthcare …
